To evaluate whether SGL 12 improved FFA-induced hepatic steatosis, expression of AMPK, PPARα, SREBP-1, FAS, and ACC—genes related to lipid metabolism—was evaluated. The gene discussed is FAS; the disease is Hepatic steatosis.